To assist clinicians in making more informed choices, MIMS has a range of evidence-based Clinical Decision Support modules developed by our expert team of pharmacists. Independent of the manufacturer’s product information, these modules are developed using international primary and tertiary references.
Modules include the ability to check for drug interactions between two or more drugs, against a patient’s health condition/s or allergies, able to be used in pregnancy, breastfeeding or checking if two or more drugs contain the same active ingredient/s.
Overview
As with all MIMS data, the data is updated regularly as new evidence becomes available to provide data that is both current and that has a high level of integrity. The modules have the following functionality:
- A warning system to facilitate safer prescribing, dispensing and administration of medicines
- The ability to review multiple medicines at one time
- A guide to ongoing management options
- References identifying the research that underpins the data
Format
Available in the MIMS digital reference products as well as in ASCII and API formats for integration into clinical software applications.
Price
Price on application. For more information on which modules are available in our wide variety of products visit the Product Pages on this website.
Features
The clinical decision support modules contain the following elements:
- Class interactions
- Severity of the potential clinical consequences of the drug interaction (range: 5: severe, 4: moderate, 3: minor, 2: caution, 1: not clinically significant, 0: not established)
- Likelihood/documentation, signifying the probability of the stated interaction occurring (range: 4: well established, 3: good, 2: limited, 1: not established)
- Observation, which includes elements of the Abbreviated and the Full data. Gives a brief summary of the interaction between the drugs selected
- Descriptions, giving comments on the most relevant information regarding the interaction. These include: Pharmacology – explanation of the mechanism of the interaction; Clinical information – relevant co-morbidity risk factors, explanation of appropriate management; Case discussions – where important for urgent clinical understanding
- Precautions, indicating the most appropriate and relevant courses of action to be pursued concerning the interaction
- References, indicating the relevant primary literature for the interaction
Editorial
The Integrated Data Solutions editorial team primarily maintains and develops our Clinical Decision Support Modules such as Drug Interactions, Drug/Allergy, DrugDisease Contraindications, Duplicate Therapy (two or more drugs containing the same active ingredients), Drugs in Pregnancy and Drugs in Lactation. These evidence-based modules can be incorporated into software used at the point-of-care by clinicians or other healthcare professionals, and help provide high-quality medical care, to minimise prescription errors and optimise drug use.
The team, based in Singapore, consists of a Managing Editor along with a team of full-time Clinical Database Research Editors and a Clinical Coder. This international team is composed of pharmacists and doctors from the UK, the Philippines, Malaysia and Singapore with working backgrounds spanning the UK, New Zealand, Australia, Malaysia and the Philippines.
The Managing Editor, a pharmacist, coordinates the team’s work. She works alongside the business team to ensure that content development meets business requirements. The Clinical Editors, consisting of pharmacists and doctors, research relevant and reliable international literature to analyse and evaluate drug information. They also develop new content for the evidence-based alert systems and update existing content on a regular basis. The Clinical Coder, also a pharmacist, assists the team in coding data to various international and local standards.
Every aspect of the team’s work is standardised. Standard operating procedures are established to provide the framework for the development of editorial content. This ensures consistency in approach and content in the database. The team takes an international perspective on content development and uses a variety of databases to improve the evidence-based content.
The diagram below shows the process undertaken by the editorial teams in Australia and Singapore in the compilation of the medicine data (Australia approved product information and internationally recognised clinical reference information) to produce the MIMS data that goes into the MIMS reference products as well as available to be integrated into clinical software applications at the point of care.
Availability
Different clinical decision support modules are available through different MIMS products.
The Drug/Drug Interaction Module is available in the following stand-alone MIMS reference products:
The following clinical decision support modules are available in the MIMS Integrated product for integration into clinical software programs. For further information on this product go to MIMS Integrated: